story of the week
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial
JAMA Oncol 2019 Jan 24;[EPub Ahead of Print], ML Disis, MH Taylor, K Kelly, JT Beck, M Gordon, KM Moore, MR Patel, J Chaves, H Park, AC Mita, EP Hamilton, CM Annunziata, HJ Grote, A von Heydebreck, J Grewal, V Chand, JL GulleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.